Drug Topics

AUGUST 30, 2023

Resources with pertinent information are essential in motivating individuals to comply with vaccine recommendations.

Vaccines 186

Vaccines 186

Pharmacy Times

AUGUST 30, 2023

Sodium chloride injection contains sodium chloride in water and is administered intravenously, which is intended for a single-dose injection to replenish fluids and electrolytes.

FDA 149

FDA 149

STAT

AUGUST 30, 2023

Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.

Insurance 143

Insurance 143

Pharmacy Times

AUGUST 30, 2023

The opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.

169

169

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

AUGUST 30, 2023

After 16 years on the market, Takeda's blockbuster attention-deficit/hyperactivity disorder (ADHD) med Vyvanse has finally reached its patent cliff. | After 16 years on the market, Takeda's blockbuster ADHD med Vyvanse has finally reached its patent cliff. And the FDA's approval of several generics comes amid a U.S. shortage of the drug.

FDA 138

FDA 138

Fierce Healthcare

AUGUST 30, 2023

Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes. | Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes.

134

134

Fierce Healthcare

AUGUST 30, 2023

In a letter sent to all states (PDF), the Centers for Medicare & Medicaid Services ( | As more Medicaid beneficiaries are wrongly kicked off the program, CMS is requiring states to reevaluate its eligibility systems and auto-renewal process.

132

132

Fierce Pharma

AUGUST 30, 2023

Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond the separation of its consumer health unit—Chief Financial Officer Joe Wolk described the compan | Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond separation of its consumer health unit—Chief Financial Officer Joe Wolk described the company’s appetite for M&A as “voracious.

129

129

Fierce Healthcare

AUGUST 30, 2023

GoodRx has launched a new feature to allow healthcare professionals to see the cost of a patient’s prescription with their insurance. | The feature, embedded in GoodRx's provider solution, surfaces a patient’s coverage and benefits at the point of care with the goal of increasing price transparency and access to drugs.

Insurance Coverage 129

Insurance Coverage Insurance 129

STAT

AUGUST 30, 2023

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.  A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic.

Hospitals 126

Hospitals 126

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

AUGUST 30, 2023

In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. | In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. Amd according to new research, this methodology is proving successful.

129

129

Fierce Pharma

AUGUST 30, 2023

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. | Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated version, but instead got a rejection letter.

FDA 126

FDA 126

Pharmacy Times

AUGUST 30, 2023

The phase 3 clinical program, CORALreef, consists of 3 trials and is likely the first of its kind for an oral PCSK9 inhibitor, according to the study authors.

123

123

Drug Topics

AUGUST 30, 2023

Image-Guided Superficial Radiation Therapy (IGSRT) directs low-level x-rays to specific areas, killing cancer cells without bleeding, pain, surgical scarring, or the need for reconstructive surgery.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

AUGUST 30, 2023

Investigators will continue to research RBX2660 in patients who are immunocompromised or who have chronic conditions with Clostridioides difficile infection.

123

123

Drug Topics

AUGUST 30, 2023

Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.

98

98

Pharmacy Times

AUGUST 30, 2023

Despite study findings showing that 1 in 5 patients hospitalized for COVID-19 developed persistent high blood pressure, many had underlying risk factors.

Hospitals 123

Hospitals 123

Drug Topics

AUGUST 30, 2023

LIB Therapeutics released data from the LIBerate-HeFH trial that showed lerodalcibep achieved statistically significant placebo adjusted reductions in mean LDL-C at Week 24 and at the mean of Weeks 22 and 24.

98

98

Fierce Pharma

AUGUST 30, 2023

After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is handing the reins to activist investor Elliott Management. | After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is linking up with Elliott Management. The CDMO giant struck a cooperation agreement with the activist investor group as it announced fourth-quarter revenues and unveiled a sweeping governance shakeup.

112

112

Pharmacy Times

AUGUST 30, 2023

Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.

132

132

Fierce Healthcare

AUGUST 30, 2023

As large employers take a step back from self-insurance, small- and medium-sized employers are taking a step forward in embracing that coverage option, according to an issue brief by the Employee B | The share of large employers offering self-insurance options to employees steadily declined since the passage of the Affordable Care Act, with it dropping to 72% in 2022, the lowest it’s been since 2010, according to the EBRI.

Insurance 110

Insurance 110

Drug Store News

AUGUST 30, 2023

In our Q&A with Stephen Mormoris, CEO of Scent Beauty, he shares how teaming up with Yellowstone star Luke Grimes is helping the fragrance reach a younger audience.

111

111

STAT

AUGUST 30, 2023

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is … cinnamon sticky bun.

100

100

Drug Store News

AUGUST 30, 2023

At NACDS’ Total Store Expo, DSN caught up with The Compliance Team’s founder and CEO to discuss how clinical services are changing the retail pharmacy space.

116

116

STAT

AUGUST 30, 2023

In inpatient child psychology, we treat children in crisis deemed at imminent risk of harm to themselves or others. I am grateful for the opportunity to try and help — but it is daunting. A study published earlier this year found an overwhelming spike in mental illness-related crises in the past decade. This is particularly true for youth, for whom mental health-related emergency room visits have doubled, with a five-fold increase in the proportion of those visits that are for suicide-rel

Hospitals 98

Hospitals 98

The Checkup by Singlecare

AUGUST 30, 2023

A fever, or body temperature of 100.4 degrees or higher , is one of the first ways your body signals that you’re sick. It can also be pretty uncomfortable. As you fight off an infection, you’ll probably want to lower your fever and reduce the symptoms that often come with it, like sweating, chills, muscle aches, and weakness. To relieve a fever with over-the-counter drugs, you have two choices: nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, or analgesics and fever reducers, like

Vaccines 98

Vaccines 98

STAT

AUGUST 30, 2023

SANTA MONICA, Calif. — Where Laurel Braitman is sitting is rather apt. Braitman, whose first book, “Animal Madness,” won her fans and TED Talk acclaim, is unmistakable in a fringed, cream-colored jacket and thick, square glasses, perched on a tall chair near the back of Zibby’s Bookshop. It’s a small, airy paperback oasis along a bougie stretch of cafés and day spas.

Hospitals 98

Hospitals 98

ISPE

AUGUST 30, 2023

Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo Logan Thomas Wed, 08/30/2023 - 11:06 iSpeak Blog iSpeak Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo Ryan Paul Mazur 30 August 2023 Building off of the success of the 2022 ISPE Annual Meeting & Expo, the 2023 ISPE Annual Meeting & Expo Program Committee has developed a robust Workshop program covering key areas in Digital Transformation (DT) and Pharma 4.0™, Quality Risk

Documentation 98

Documentation Vaccines 98

STAT

AUGUST 30, 2023

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. K RAS, one of the most common genetic mutations in cancer, has been one of the most tantalizing oncogenic targets for drug developers since its discovery four decades ago. An altered KRAS gene can drive cells to divide uncontrollably, propelling them down the path towards malignancy.

97

97

ISPE

AUGUST 30, 2023

Meet the 2023 FOYA Operations Category Winner: WuXi Biologics Ireland Limited Trudy Patterson Wed, 08/30/2023 - 15:27 iSpeak Blog iSpeak Meet the 2023 FOYA Operations Category Winner: WuXi Biologics Ireland Limited Marcy Sanford 30 August 2023 Facility of the Year Award (FOYA) Winners in the Operations category exemplify the application of novel tools and approaches to delivering projects that improved efficiencies, overcame unusual challenges, promoted effectiveness, and organized stakeholders

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

AUGUST 30, 2023

According to a report by Transparency Market Research Inc, the global cell and gene therapy (CGT) manufacturing quality control (QC) market is anticipated to value $2.8 billion in 2031. It is projected to expand at a CAGR of 24.6 percent from 2023 to 2031. Comparatively, the market is expected to value $463.1 million by the end of 2023. With increasing research and development in the cell and gene therapy field, the demand for optimal quality control is needed to ensure the safe and efficient ma

95

95

Pharmacy Times

AUGUST 30, 2023

Any new prices established after negotiations will be effective on January 1, 2026.

132

132

PharmaVoice

AUGUST 30, 2023

Experts have determined the strains of this year’s flu season — now the question is whether people are too fatigued by the pandemic to be immunized.

Immunization 98

Immunization Vaccines 98

Pharmacy Times

AUGUST 30, 2023

In this limited series, we speak with experts to understand the new frontier of anti-obesity drugs, as well as concerns and questions that still remain.

94

94